Royalty Pharma Plc (RPRX)
Royalty Pharma Market Cap : 23.43B for May 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Johnson & Johnson | 545.74B |
| Zymeworks, Inc. | 1.761B |
| ANI Pharmaceuticals, Inc. | 1.774B |
| Corcept Therapeutics, Inc. | 6.051B |
| Elanco Animal Health, Inc. | 9.919B |
Market Cap Related Metrics
| PE Ratio | 27.68 |
| PS Ratio | 11.41 |
| Price to Book Value | 3.401 |
| Price to Free Cash Flow | 48.50 |
| Price | 52.85 |
| Earnings Yield | 3.61% |
| Operating PE Ratio | 16.80 |
| Normalized PE Ratio | 27.60 |